Evogene Announces Annual General Meeting for August 2025

Evogene ( (EVGN) ) has shared an update.

Evogene Ltd. has announced its upcoming Annual General Meeting of Shareholders, scheduled for August 11, 2025, at its offices in Rehovot, Israel. The meeting will address several key proposals including the re-election and election of directors, amendments to compensation packages, an increase in registered share capital, and the re-appointment of its accounting firm. Shareholders of record as of June 23, 2025, are entitled to vote, and the company’s board recommends voting in favor of the proposals. This meeting is significant for Evogene’s governance and strategic direction, impacting its operational and financial framework.

The most recent analyst rating on (EVGN) stock is a Buy with a $30.00 price target. To see the full list of analyst forecasts on Evogene stock, see the EVGN Stock Forecast page.

Spark’s Take on EVGN Stock

According to Spark, TipRanks’ AI Analyst, EVGN is a Neutral.

Evogene’s stock is weighed down by weak financial performance, characterized by persistent losses and negative cash flow. Although there are some positive technical signals, the valuation remains unattractive due to operational losses. The recent earnings call provided mixed insights, with strategic expense reductions overshadowed by a significant revenue decline.

To see Spark’s full report on EVGN stock, click here.

More about Evogene

Evogene Ltd. operates in the biotechnology industry, focusing on the development of novel products for life science markets. The company is involved in various sectors including agriculture, human health, and industrial applications, leveraging its computational predictive biology platform to enhance product development.

Average Trading Volume: 2,104,865

Technical Sentiment Signal: Sell

Current Market Cap: $10.14M

Learn more about EVGN stock on TipRanks’ Stock Analysis page.